Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E4/DRSP versus EE/LNG and EE/DRSP on hemostasis, endocrine and metabolic parameters
NL-OMON43221Active, not recruiting
- Sponsor
- Estetra SRL
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of estetrol, drospirenone, ethinyl estradiol and avatrombopag in contraception, sponsored by Estetra SRL. Primary endpoints: Hemostatic parameters, Endocrine parameters and 3 more. Started Sep 2016; status: active, not recruiting.
02
Drugs
estetroldrospirenoneethinyl estradiolavatrombopag
03
Conditions
contraception
Beyond the preview
Go deeper on NL-OMON43221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43221.